Mark Vincent C. dela Cerna

Also affiliated with University of Aberdeen, Georgia Southern University

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicineEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A screen of FDA-approved drugs identifies inhibitors of Protein Tyrosine Phosphatase 4A3 (PTP4A3 or PRL-3)”.

A screen of FDA-approved drugs identifies inhibitors of Protein Tyrosine Phosphatase 4A3 (PTP4A3 or PRL-3)

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.24.098665

N/A

0DataRank · unranked

3 citations

Mark Vincent C. dela Cerna, Caroline N. Smith, Blaine G. Patty, Donghan Lee, Jessica S. Blackburn +1 more

A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3)

Scientific Reports(2021)10.1038/s41598-021-89668-5

N/A

0DataRank · unranked

15 citations

Mark Vincent C. dela Cerna, Caroline N. Smith, Shilpa Sampathi, Blaine G. Patty, Donghan Lee +2 more

Expansion of the known poly(aspartic acid) hydrolases through the identification of four new PahZ1 homologs

Protein Engineering Design and Selection(2025)10.1093/protein/gzag006

N/A

0DataRank · unranked

0 citations

Chad A. Brambley, Thi Loan Ho, Waylan Callaway, Amanda L. Jansch, K. Phillip Taylor +11 more